Medisix Therapeutics

About:

Medisix Therapeutics is a provider of immune engineering company developing novel cellular therapies.

Website: http://www.medisixtx.com

Top Investors: OUP (Osage University Partners), Lightstone Ventures, Temasek Holdings

Description:

Medisix Therapeutics is a Singapore-based immune engineering company developing novel cellular therapies to address T cell malignancies. Their technology platform originates from world expert in translational immunology, Professor Dario Campana, MD, PhD, a physician scientist who pioneered chimeric antigen receptor T cell (CAR-T) biology. Their programs utilize proprietary immune engineering approaches that enable T cell leukemias and lymphomas to be targeted with cell therapy.